TRANSFORMATION BY MYC PREVENTS FUSION BUT NOT BIOCHEMICAL DIFFERENTIATION OF C2C12 MYOBLASTS - MECHANISMS OF PHENOTYPIC CORRECTION IN MIXED CULTURE WITH NORMAL-CELLS

被引:45
作者
CRESCENZI, M
CROUCH, DH
TATO, F
机构
[1] UNIV ROMA LA SAPIENZA,DIPARTIMENTO BIOL CELLULARE & SVILUPPO,I-00185 ROME,ITALY
[2] BEATSON INST CANC RES,GARSCUBE ESTATE,GLASGOW G61 1BD,SCOTLAND
关键词
D O I
10.1083/jcb.125.5.1137
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To study the effects of myc oncogene on muscle differentiation, we infected the murine skeletal muscle cell line C2C12 with retroviral vectors encoding various forms of avian c- or v-myc oncogene. myc expression induced cell transformation but, unlike many other oncogenes, prevented neither biochemical differentiation, nor commitment (irreversible withdrawal from the cell cycle). Yet, myotube formation by fusion of differentiated cells was strongly inhibited. Comparison of uninfected C2C12 myotubes with differentiated myc-expressing C2C12 did not reveal consistent differences in the expression of several muscle regulatory or structural genes. The present results lead us to conclude that transformation by myc is compatible with differentiation in C2C12 cells. myc expression induced cell death under growth restricting conditions. Differentiated cells escaped cell death despite continuing expression of myc, suggesting that the muscle differentiation programme interferes with the mechanism of myc-induced cell death. Cocultivation of v-myc-transformed C2C12 cells with normal fibroblasts or myoblasts restored fusion competence and revealed two distinguishable mechanisms that lead to correction of the fusion defect.
引用
收藏
页码:1137 / 1145
页数:9
相关论文
共 49 条
[1]   INTERACTION OF RETROVIRAL ONCOGENES WITH THE DIFFERENTIATION PROGRAM OF MYOGENIC CELLS [J].
ALEMA, S ;
TATO, F .
ADVANCES IN CANCER RESEARCH, 1987, 49 :1-28
[2]  
ALEMA S, 1994, IN PRESS SEMIN CELL
[3]   ONCOGENIC ACTIVITY OF THE C-MYC PROTEIN REQUIRES DIMERIZATION WITH MAX [J].
AMATI, B ;
BROOKS, MW ;
LEVY, N ;
LITTLEWOOD, TD ;
EVAN, GI ;
LAND, H .
CELL, 1993, 72 (02) :233-245
[4]  
ANGELIS MGC, 1992, J CELL BIOL, V116, P1243
[5]   IMMUNOCHEMICAL ANALYSIS OF MYOSIN HEAVY-CHAIN DURING AVIAN MYOGENESIS INVIVO AND INVITRO [J].
BADER, D ;
MASAKI, T ;
FISCHMAN, DA .
JOURNAL OF CELL BIOLOGY, 1982, 95 (03) :763-770
[6]   FUNCTIONAL ANTAGONISM BETWEEN C-JUN AND MYOD PROTEINS - A DIRECT PHYSICAL ASSOCIATION [J].
BENGAL, E ;
RANSONE, L ;
SCHARFMANN, R ;
DWARKI, VJ ;
TAPSCOTT, SJ ;
WEINTRAUB, H ;
VERMA, IM .
CELL, 1992, 68 (03) :507-519
[7]  
BIGNAMI M, 1988, ONCOGENE, V2, P509
[8]   SPECIFIC VIRAL ONCOGENES CAUSE DIFFERENTIAL-EFFECTS ON CELL-TO-CELL COMMUNICATION, RELEVANT TO THE SUPPRESSION OF THE TRANSFORMED PHENOTYPE BY NORMAL-CELLS [J].
BIGNAMI, M ;
ROSA, S ;
FALCONE, G ;
TATO, F ;
KATOH, F ;
YAMASAKI, H .
MOLECULAR CARCINOGENESIS, 1988, 1 (01) :67-75
[9]   MYF-6, A NEW MEMBER OF THE HUMAN GENE FAMILY OF MYOGENIC DETERMINATION FACTORS - EVIDENCE FOR A GENE-CLUSTER ON CHROMOSOME-12 [J].
BRAUN, T ;
BOBER, E ;
WINTER, B ;
ROSENTHAL, N ;
ARNOLD, HH .
EMBO JOURNAL, 1990, 9 (03) :821-831
[10]   GROWTH-FACTOR CONTROL OF SKELETAL-MUSCLE DIFFERENTIATION - COMMITMENT TO TERMINAL DIFFERENTIATION OCCURS IN G1 PHASE AND IS REPRESSED BY FIBROBLAST GROWTH-FACTOR [J].
CLEGG, CH ;
LINKHART, TA ;
OLWIN, BB ;
HAUSCHKA, SD .
JOURNAL OF CELL BIOLOGY, 1987, 105 (02) :949-956